구강용 박막 필름 시장 규모, 점유율, 성장 분석 : 제품별, 적응 질환별, 유통 채널별, 지역별 - 산업 예측(2025-2032년)

Global Oral Thin Films Market size was valued at USD 3.46 billion in 2023 and is poised to grow from USD 3.78 billion in 2024 to USD 7.7 billion by 2032, growing at a CAGR of 9.3% during the forecast period (2025-2032).

The global oral thin films market is emerging as a vital area of the pharmaceutical industry, characterized by the production of dissolvable strips that enhance oral drug delivery. These films offer a convenient and patient-centric alternative to traditional tablets and capsules, improving ease of administration, accurate dosage, and patient compliance, particularly for pediatric and geriatric populations. While the demand for innovative drug delivery systems propels market growth, challenges such as the complex manufacturing processes, regulatory hurdles, and competition from established dosage forms persist. Nevertheless, opportunities abound in personalized medicine, pediatric needs, and self-administered therapies, as well as expanding applications in the nutraceutical sector, positioning oral thin films as a significant player in the evolving healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oral Thin Films market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oral Thin Films Market Segmental Analysis

Global Oral Thin Films Market is segmented by Product, Disease Indication, Distribution Channel and region. Based on Product, the market is segmented into Sublingual Film and Fast Dissolving Dental/Buccal Film. Based on Disease Indication, the market is segmented into Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Oral Thin Films Market

A significant factor propelling the Global Oral Thin Films market is the rising patient preference for non-invasive drug delivery systems. In 2022, an increasing number of patients favored oral thin films over conventional oral medications like tablets and injections, appreciating their convenience and user-friendliness. The quick disintegration and ease of administration associated with these films enhance medication compliance, making them an attractive option for many. Additionally, the COVID-19 pandemic heightened awareness of safety in healthcare practices, further boosting the demand for non-invasive delivery methods. Consequently, the shift towards oral thin films as a preferred choice in medication delivery is becoming more pronounced.

Restraints in the Global Oral Thin Films Market

In 2022, one of the major obstacles impacting the global oral thin films market was the intricate manufacturing processes tied to these specialized dosage forms. The production and scaling of oral thin films necessitate advanced technology, specialized knowledge, and stringent quality assurance measures. This complexity not only raises manufacturing costs but also restricts the accessibility and affordability of oral thin films for consumers. As a result, these factors collectively pose challenges to market expansion, potentially stifling innovation and limiting the reach of these products in the healthcare sector. Consequently, addressing these manufacturing hurdles is crucial for fostering market growth.

Market Trends of the Global Oral Thin Films Market

The Global Oral Thin Films market is currently influenced by a notable trend characterized by the challenges posed by complex manufacturing processes. As of 2022, these intricate production requirements have emerged as a significant restraint, demanding advanced equipment and specialized expertise, thereby resulting in higher associated costs. This complexity hampers not only the scalability of oral thin films but also their affordability, potentially stunting market growth. Consequently, while there is a growing demand for innovative and convenient drug delivery systems, the barriers posed by manufacturing intricacies are prompting industry players to pursue technological advancements and streamlined processes to enhance production efficiency and market accessibility.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement

Global Oral Thin Films Market Size by Product & CAGR (2025-2032)

• Market Overview
• Sublingual Film
• Fast Dissolving Dental/Buccal Film

Global Oral Thin Films Market Size by Disease Indication & CAGR (2025-2032)

• Market Overview
• Schizophrenia
• Migraine
• Opioid Dependence
• Nausea & Vomiting
• Others

Global Oral Thin Films Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Oral Thin Films Market Size & CAGR (2025-2032)

• North America (Product, Disease Indication, Distribution Channel)
  • US
  • Canada
• Europe (Product, Disease Indication, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Disease Indication, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Disease Indication, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Disease Indication, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis International AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sumitomo Dainippon Pharma Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indivior PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioDelivery Sciences International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aquestive Therapeutics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IntelGenx Technologies Corp. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tesa Labtec GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CURE Pharmaceutical Holding Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZIM Laboratories Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NAL Pharma (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations